Brief: Endra Life Sciences Approves A Reverse Stock Split Ratio Of 1-For-20
Dec 2 (Reuters) - ENDRA Life Sciences Inc NDRA.O :
* ENDRA LIFE SCIENCES INC - FOLLOWING THE SPECIAL MEETING,
THE
BOARD APPROVED A REVERSE STOCK SPLIT RATIO OF 1-FOR-20
* ENDRA LIFE SCIENCES INC - COMPANY INTENDS TO EFFECT THE
REVERSE
STOCK SPLIT PRIOR TO DECEMBER 31, 2022
Further company coverage: NDRA.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences